Updated:
Publics Venture Capital
Publics Venture Capital is a venture capital firm in China focused on new materials, advanced manufacture, biopharmaceuticals, and new-generation information...
Overview
Publics Venture Capital is a venture capital firm in China focused on new materials, advanced manufacture, biopharmaceuticals, and new-generation information technology. The firm has made 16 investments, including a Series B investment in Zhaoqing Jincheng Metal on August 15, 2022. Publics Venture Capital has 2 portfolio exits, with Innoscience exiting on December 30, 2024.
General information
Firm type
Venture Capital
Location
Region
Asia
Country
China
City
Guangzhou
Corporate office
Guangzhou, China
Frequently asked questions
What is Publics Venture Capital's geographic focus?
Operations center on Guangzhou and the Greater Bay Area — the Pearl River Delta megaregion encompassing Shenzhen, Hong Kong, and the manufacturing cities of Guangdong. This corridor is one of the densest concentrations of hardware, deep-tech, and consumer-technology startups in China.
Does Publics Venture Capital invest outside of China?
No cross-border investments, offshore vehicles, or non-China portfolio companies have been identified from public record. The firm's domestic registration and sole Guangzhou office point to a China-only deployment model.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: